sanofi-aventis licenses CureDM's Pancreate

CureDM Inc. (Wilmington, Del.) granted sanofi-aventis Group (Euronext:SAN; NYSE:SNY) an exclusive, worldwide license to develop and commercialize Pancreate proisletide, which is in development for Typ...